TAA05 Cell Injection in the Treatment of Recurrent / Refractory Acute Myeloid Leukemia
This is a clinical study of ytaa05 cell injection in the treatment of patients with recurrent / refractory acute myeloid leukemia.The purpose is to evaluate the safety and preliminary efficacy of FLT3 car-t cells in patients with recurrent / refractory FLT3 positive acute myeloid leukemia.#TAA05 cell injection is a T cell targeting FLT3 chimeric antigen receptor#
100 项与 TAA5 CAR T 相关的临床结果
100 项与 TAA5 CAR T 相关的转化医学
100 项与 TAA5 CAR T 相关的专利(医药)
100 项与 TAA5 CAR T 相关的药物交易